World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
10594
World Ranking
4490
National Ranking
2031

Best Publications

  • Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

    Unknown

  • Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

    Unknown

  • Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

    Nicola P Klein;Ned Lewis;Kristin Goddard;Bruce Fireman

  • Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.

    Mark G Thompson;Edward Stenehjem;Shaun Grannis;Sarah W Ball

  • Is Maternal Influenza or Fever During Pregnancy Associated with Autism or Developmental Delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study

    Ousseny Zerbo;Ousseny Zerbo;Ana-Maria Iosif;Cheryl Walker;Sally J Ozonoff

  • Maternal Infection During Pregnancy and Autism Spectrum Disorders.

    Ousseny Zerbo;Yinge Qian;Cathleen Yoshida;Judith K. Grether

  • Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

    Unknown

  • Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

    Unknown

  • Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation.

    K L Jones;L A Croen;C K Yoshida;L Heuer

  • Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

    Unknown

  • COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021.

    Hilda Razzaghi;Mehreen Meghani;Cassandra Pingali;Bradley Crane

  • Immune mediated conditions in autism spectrum disorders.

    Ousseny Zerbo;Albin Leong;Lisa Barcellos;Pilar Bernal

  • Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.

    Peter J Embi;Matthew E Levy;Allison L Naleway;Palak Patel

  • Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

    Unknown

  • Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder.

    Ousseny Zerbo;Yinge Qian;Cathleen Yoshida;Bruce H. Fireman

  • Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

    Unknown

  • Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: The Early Markers for Autism (EMA) study: A case-control study

    Ousseny Zerbo;Cathleen Yoshida;Judith K. Grether;Judith K. Grether;Judith A Van de Water

  • Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

    Unknown

  • Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.

    Catherine H Bozio;Shaun J Grannis;Allison L Naleway;Toan C Ong

  • Infection and Fever in Pregnancy and Autism Spectrum Disorders: Findings from the Study to Explore Early Development.

    Lisa A. Croen;Yinge Qian;Paul Ashwood;Ousseny Zerbo

Frequent Co-Authors

Nicola P. Klein
Nicola P. Klein Kaiser Permanente
Bruce Fireman
Bruce Fireman Kaiser Permanente
Lisa A. Croen
Lisa A. Croen Kaiser Permanente
Allison L. Naleway
Allison L. Naleway Kaiser Permanente
Robin L Hansen
Robin L Hansen University of California, Davis
Paul Ashwood
Paul Ashwood University of California, Davis
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Mark G. Thompson
Mark G. Thompson Centers for Disease Control and Prevention
Frank DeStefano
Frank DeStefano Centers for Disease Control and Prevention
Manjusha Gaglani
Manjusha Gaglani Baylor College of Medicine

External Links

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ousseny Zerbo